BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 3092888)

  • 21. The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level.
    Petri M; Rheinschmidt M; Whiting-O'Keefe Q; Hellmann D; Corash L
    Ann Intern Med; 1987 Apr; 106(4):524-31. PubMed ID: 3103510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical manifestations and laboratory findings in patients with lupus anticoagulants.
    Kornberg A; Silber L; Yona R; Kaufman S
    Eur J Haematol; 1989 Jan; 42(1):90-5. PubMed ID: 2914599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of four laboratory tests for lupus anticoagulant.
    Stark RA; Gordon S
    Pathology; 1990 Apr; 22(2):122-3. PubMed ID: 2122400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of the lupus anticoagulant.
    Espinoza LR; Hartmann RC
    Am J Hematol; 1986 Jul; 22(3):331-7. PubMed ID: 3087160
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies on phospholipids in the action of a lupus coagulation inhibitor.
    Exner T; Rickard KA; Kronenberg H
    Pathology; 1975 Oct; 7(4):319-28. PubMed ID: 1223721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of test methods for the lupus anticoagulant: international survey on lupus anticoagulants-I (ISLA-1).
    Exner T; Triplett DA; Taberner DA; Howard MA; Harris EN
    Thromb Haemost; 1990 Nov; 64(3):478-84. PubMed ID: 2128977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The antiphospholipid syndrome.
    Many A; Gitel S; Pauzner R
    Isr J Med Sci; 1989 Dec; 25(12):674-7. PubMed ID: 2515169
    [No Abstract]   [Full Text] [Related]  

  • 28. Relative sensitivity of different tests in the detection of low titer lupus anticoagulants.
    Lesperance B; David M; Rauch J; Infante-Rivard C; Rivard GE
    Thromb Haemost; 1988 Oct; 60(2):217-9. PubMed ID: 3146139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Relation of antiphospholipid antibodies to thrombotic phenomena and clinical activity of systemic lupus erythematosus].
    Font J; Cervera R; Casals FJ; Bové A; Guerrero A; López-Soto A; Ingelmo M; Urbano-Márquez A
    Med Clin (Barc); 1988 Mar; 90(12):490-3. PubMed ID: 3134583
    [No Abstract]   [Full Text] [Related]  

  • 30. Detection of antiphospholipid antibodies by ELISA-method with bovine thromboplastin as antigen.
    López-Soto A; Casals FJ; Font J; Cervera R; Ingelmo M
    Thromb Res; 1989 Mar; 53(6):623-8. PubMed ID: 2499948
    [No Abstract]   [Full Text] [Related]  

  • 31. Lupus anticoagulant: clinical significance in anticardiolipin positive patients with systemic lupus erythematosus.
    McHugh NJ; Moye DA; James IE; Sampson M; Maddison PJ
    Ann Rheum Dis; 1991 Aug; 50(8):548-52. PubMed ID: 1909518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Circulating anticoagulants. Clinical conditions of diagnosis].
    Godeau P; Blétry O; Piette JC; Wechsler B
    Rev Med Interne; 1985 Dec; 6(5):523-41. PubMed ID: 3938557
    [No Abstract]   [Full Text] [Related]  

  • 33. The automated modified Russell viper venom time test for the lupus anticoagulant.
    Petri M; Nelson L; Weimer F; Anderson D; Darlington T; Corash L
    J Rheumatol; 1991 Dec; 18(12):1823-5. PubMed ID: 1795319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The anti-phospholipid antibody syndrome in a 77 year old man with digital gangrene.
    Roche SW; Niriella DC; O'Mahoney A; Cayley AC
    Postgrad Med J; 1989 Nov; 65(769):837-9. PubMed ID: 2515530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coagulation assays for the lupus anticoagulant: review and critique of current methodology.
    Triplett DA
    Stroke; 1992 Feb; 23(2 Suppl):I11-4. PubMed ID: 1561667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Circulating anticoagulants of the lupus type and pregnancy].
    Edelman P
    J Gynecol Obstet Biol Reprod (Paris); 1988; 17(7):931. PubMed ID: 3146596
    [No Abstract]   [Full Text] [Related]  

  • 37. Lupus anticoagulant testing with optical end point automation.
    Luddington R; Scales C; Baglin T
    Thromb Res; 1999 Nov; 96(3):197-203. PubMed ID: 10588462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kaolin clotting time and dilute Russell's viper venom time distinguish between prothrombin-dependent and beta 2-glycoprotein I-dependent antiphospholipid antibodies.
    Galli M; Finazzi G; Bevers EM; Barbui T
    Blood; 1995 Jul; 86(2):617-23. PubMed ID: 7605991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Common variable immune deficiency syndrome associated with lupus anticoagulant.
    Ruggieri AP; Galbraith RM; Lazarchick J
    Clin Exp Rheumatol; 1985; 3(1):71-3. PubMed ID: 3919983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of four coagulation tests to detect plasma lupus anticoagulants.
    Saxena R; Saraya AK; Kotte VK; Singh YN; Prasad L; Malviya AN
    Am J Clin Pathol; 1991 Dec; 96(6):755-8. PubMed ID: 1746492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.